The Alopecia Areata Global Market Report 2023, provides comprehensive information on the alopecia areata market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Alopecia Areata Market’s Growth:
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report
The global alopecia areata market is expected to grow from $3.08 billion in 2022 to $3.31 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The alopecia areata market is expected to reach $4.35 billion in 2027 at a CAGR of 7.1%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12596&type=smp
Innovative drug approval is a key trend gaining popularity in the alopecia areata market. Major companies operating in the alopecia areata market are focused on obtaining new drug approvals to strengthen their market position and gain a competitive advantage. For instance, in June 2023, Pfizer Inc., a US-based biotechnology and pharmaceutical company, announced that the US Food and Drug Administration (FDA), a US-based federal agency of the Department of Health and Human Services responsible for protecting public health, had approved LITFULOTM (ritlecitinib), the first and only treatment for severe alopecia areata approved for patients as young as 12. It is a once-daily oral treatment for alopecia areata, an autoimmune condition for which there were previously no FDA-approved treatments for teenagers and few options for adults. LITFULO is a kinase inhibitor that blocks Janus kinase 3 (JAK3) and the tyrosine kinase family of kinases found in hepatocellular carcinoma (TEC).
The alopecia areata market is segmented:
1) By Type: Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia, Other Types
2) By Treatment: Medical Treatments, Natural Treatment, Other Treatments
3) By Diagnosis: Trichoscopy, Skin Biopsy, Other Diagnoses
4) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
North America was the largest region in the alopecia areata market in 2022.
The table of contents in TBRC’s alopecia areata market report includes:
- Executive Summary
- Alopecia Areata Market Characteristics
- Alopecia Areata Market Trends And Strategies
- Alopecia Areata Market – Macro Economic Scenario
- Global Alopecia Areata Market Size and Growth
….………………………………………………………………………………….
- Global Alopecia Areata Market Competitive Benchmarking
- Global Alopecia Areata Market Competitive Dashboard
- Key Mergers And Acquisitions In The Alopecia Areata Market
- Alopecia Areata Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
